Stock listing

NASDAQ:NBRV Nabriva Therapeutics AG Stock

Follow Nabriva Therapeutics AG into a list and get an email when it puts out news.

Delisted NASDAQ:NBRV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:NBRV
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Nabriva Therapeutics AG on 6ix

Calls
7 calls with a replay · 7 with a transcript · latest Nov 10, 2022
Decks
11 decks · latest Apr 15, 2021

Events

CallWhenStatus
Nabriva Therapeutics (NBRV) Q3 2022 Earnings CallThu, Nov 10, 2022 · 3:30 AM ETReplay
Nabriva Therapeutics (NBRV) Q2 2022 Earnings CallWed, Aug 03, 2022 · 4:30 PM ETReplay
Nabriva Therapeutics (NBRV) Q4 2021 Earnings CallTue, Mar 29, 2022 · 4:30 PM ETReplay
Nabriva Therapeutics (NBRV) Q3 2021 Earnings CallTue, Nov 09, 2021 · 4:30 PM ETReplay
Nabriva Therapeutics (NBRV) Q2 2021 Earnings CallThu, Aug 05, 2021 · 4:30 PM ETReplay
Nabriva Therapeutics (NBRV) Q1 2021 Earnings CallMon, Apr 05, 2021 · 4:30 PM ETReplay
Nabriva Therapeutics (NBRV) Q4 2020 Earnings CallThu, Mar 11, 2021 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (April 2021)Investor deck30 slidesApr 15, 2021
Q3 2019 Earnings PresentationEarnings27 slidesNov 12, 2019
Technical Presentation (May 2018)Technical36 slidesMay 21, 2018
Investor Presentation (November 2017)Investor deck57 slidesNov 7, 2017
Conference Presentation (September 2017)Conference28 slidesSep 18, 2017
Investor Day (June 2017)Investor day49 slidesJun 19, 2017
Investor Presentation (April 2017)Investor deck35 slidesApr 5, 2017
Investor Presentation (February 2017)Investor deck34 slidesFeb 15, 2017
Investor Presentation (January 2017)Investor deck29 slidesJan 9, 2017
Investor Presentation (April 2016)Investor deck31 slidesApr 12, 2016
All 11 decks
DeckKindSlidesDate
Investor Presentation (November 2015)Investor deck17 slidesNov 10, 2015

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Stephen Webster
Other companies: Cullinan Therapeutics, Inc. (Chair of the Audit Committee · Since at least Jan 7, 2021); NextCure, Inc. (Director · Since at least May 8, 2019); Gritstone bio, Inc. (Director · Apr 26, 2024 – Apr 4, 2025 · Past); Tcr2 Therapeutics Inc (Director · Apr 30, 2020 – Jun 1, 2023 · Past); Viking Therapeutics, Inc. (Director · Apr 28, 2015 – Jan 2, 2020 · Past); Spark Therapeutics Inc (CHIEF FINANCIAL OFFICER · Jan 29, 2015 – Dec 17, 2019 · Past); Optimer Pharmaceuticals Inc (Chief Financial Officer · Jun 25, 2012 – Oct 24, 2013 · Past); Adolor Corp (SVP, Finance & CFO · Sep 9, 2010 – Dec 12, 2011 · Past)
Director · Dec 30, 2016 – Aug 2, 2022 · Past
John Peter Wolf III
Other companies: Aceragen Inc. (General Counsel · Dec 10, 2014 – Dec 10, 2014 · Past); Viropharma Inc (VP, General Counsel · Jun 10, 2013 – Jan 24, 2014 · Past)
General Counsel and Corp. Sec. · Dec 30, 2016 – Dec 30, 2016 · Past
Colin MD BroomDirector · Aug 2, 2022 – Aug 2, 2022 · Past
Elyse G SeltzerChief Medical Officer · Dec 30, 2016 – Jun 23, 2017 · Past
Francesco Maria LavinoChief Commercial Officer · Jul 10, 2017 – Sep 30, 2020 · Past
Jennifer SchranzChief Medical Officer · Sep 30, 2020 – Feb 28, 2021 · Past
Lisa DaltonDirector · Jun 2, 2021 – Jul 31, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Nabriva Therapeutics AG.